Employer
German Cancer Research Center, Heidelberg, Germany
Description
Therapeutic monoclonal antibodies (mAbs) and CAR T cell-based immunotherapies are revolutionizing the treatment landscape in MM. Examples include, but are not limited to, monoclonal antibodies targeting CD38, bispecific antibodies targeting GPRC5D × CD3, and BCMA × CD3. Despite being in clinical use, the molecular binding mechanisms of antibodies and the target antigens remain elusive. The prospective doctoral candidate will be trained and is expected to design and implement advanced fluorescence imaging experimental workflows (SMLM and/or lightsheet and/or expansion microscopy) with the aim of discerning the intricate spatial organization of BCMA and GPRC5D antigens on MM cell membranes when treated with traditional and bispecific mAbs, with the final aim of understanding mechanisms of antigen escape in MM treatment.
Please mention Science HR when applying
Share
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 111
- Comments 0
Recommended
Post a comment
Comments
More jobs
-
Microbial foods for sustainable nutrition (ref. BAP-2026-401) University of Leuven
-
PhD position in Synthetic Programming of Bacterial Population Behavior (ref. BAP-2026-418) University of Leuven
-
PhD position on ‘Laser scatter imaging for plant stress detection in greenhouse crops' (ref. BAP-2026-407) University of Leuven
-
PhD researcher at the Department of Work and Organisation Studies (ref. BAP-2026-434) University of Leuven
